IMMUNIC, INC. — Director's Dealing 2019

Oct 15, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2019-10-11

Reporting Person: HOWSON TAMAR D (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-11	Stock Option	$9.54	A	29959	Acquired	2029-10-11	Common Stock (29959)	Direct

Footnotes

F1: The option to purchase 9,986 shares vests in monthly increments over a period of one year from the grant date, and the option to purchase 19,973 shares vests in monthly increments over a period of three years from the grant date.